Lisa C. McClain bought Dolby Laboratories (NYSE: DLB)
Lisa C. McClain bought DLB · disclosed October 22, 2025
Lisa C. McClain, a MI House member representing District 9, purchased $1,001 - $15,000 of Dolby Laboratories (DLB) on September 11, 2025. Filings associated with Lisa C. McClain disclosed 2 other DLB transactions (1 purchase and 1 sale) in the 12 months before this trade. Shares of DLB have fallen 14.1% since the first observed purchase on June 24, 2025. The filing was publicly disclosed on October 22, 2025; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Lisa C. McClain's complete filing history, visit Lisa C. McClain's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on DLB break down as 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell.
- DLB carries a Risk Score of 86 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Lisa C. McClain bought DLB in the amount range of $1,001 - $15,000 on September 11, 2025, filed under the STOCK Act.
- The filing lists Spouse as the transaction owner and was disclosed 41 days after the trade.
- The asset description in the filing reads 'Dolby Laboratories Common Stock (DLB) [ST].'
- Filings associated with Lisa C. McClain disclosed 2 other DLB transactions (1 purchase and 1 sale) in the 12 months before this trade.
- Shares of DLB have fallen 14.1% since the first observed purchase on June 24, 2025.
- DLB carried a Q Score of 70.9 in its equity peer group as of September 8, 2026.
- DLB carried a Squeeze Score of 40 as of September 9, 2026.
Did Lisa C. McClain buy or sell DLB?
The Periodic Transaction Report covers a single purchase involving DLB on September 11, 2025. The filed amount range is $1,001 - $15,000. The asset description reads 'Dolby Laboratories Common Stock (DLB) [ST]', as submitted by the filer. The report was submitted on October 22, 2025. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Lisa C. McClain (House) | Buy | DLB | $1,001 - $15,000 | September 11, 2025 | October 22, 2025 |
What other DLB trades has Lisa C. McClain disclosed in the past 12 months?
Filings associated with Lisa C. McClain disclosed 2 other DLB transactions (1 purchase and 1 sale) in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| August 4, 2025 | Sell | Spouse | $1,001 - $15,000 | Filing unavailable |
| June 24, 2025 | Buy | Spouse | $1,001 - $15,000 | Filing unavailable |
What does the filing show, and what does it not show?
The filing reports a purchase involving DLB by Lisa C. McClain in the amount range of $1,001 - $15,000, with Spouse listed as the owner. It does not establish Lisa C. McClain's total holdings in DLB, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Dolby Laboratories Common Stock (DLB) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Lisa C. McClain's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Lisa C. McClain disclosed 2 other DLB transactions (1 purchase and 1 sale) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded DLB?
Quantellect's current database lists these recent DLB disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| No recent disclosures by other members are available. | ||||
How has Lisa C. McClain's disclosed trading performed?
Lisa C. McClain holds a Quantellect Q Score of 86 (strong), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #12 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Lisa C. McClain DLB trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Lisa C. McClain buy or sell DLB?
According to the disclosure, Lisa C. McClain purchased DLB on September 11, 2025.
What amount was reported for the DLB transaction?
The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated September 11, 2025, and it was disclosed on October 22, 2025.
Where can I see Lisa C. McClain's other congressional trades?
Quantellect lists Lisa C. McClain's complete disclosed trade history on the member profile. Lisa C. McClain's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.